August 20, 2026 02:58 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Vijay govt calls for action to stop students, youth from joining CJP, Left protests | Kolkata hotel fire kills 9: Bengal Minister Agnimitra Paul targets ex-TMC govt, CESC over licences | Kolkata hotel fire: 9 Bangladeshi nationals, including women and a child, die in massive blaze | Tarun Tejpal faces life term? Goa govt moves Supreme Court after 2013 rape conviction | Supreme Court rejects ‘less painful’ death penalty plea, but leaves door open for future change | ‘Vulgarity and disgust’: DMK attacks Vijay over Trisha salute at I-Day event | ‘Take Gyanesh Kumar to the US’: Congress mocks Trump over praise for India’s voter ID system | Big relief for Imran Khan: Pakistan Supreme Court orders hospital transfer amid health fears | Trump praises India’s voter ID system, pushes SAVE America Act | Trump's shock threat to bomb Oman: US President warns ally over Iran deal and Hormuz crisis
Serum Institute
PIB

Had a good interaction with team: Indian PM Narendra Modi tweets after visiting Serum Institute of India

| @indiablooms | Nov 29, 2020, at 12:38 am

Pune: Indian PM Narendra Modi on Saturday visited Pune's Serum Institute of India, which is working on the coronavirus vaccine, and interacted with the team at the Institute.

"They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing," read a government statement.

In a tweet, the Prime Minister said, "Had a good interaction with the team at Serum Institute of India. They shared details about their progress so far on how they plan to further ramp up vaccine manufacturing. Also took a look at their manufacturing facility."  

The institute's CEO Adar Poonawala thannked PM and tweeted: "Thank you @narendramodi for visiting @SerumInstIndia . We share your vision and continue to work towards ensuring a safe and secure India."

The PM earlier in the day visited  Bharat Biotech International Limited (BBIL) at Genome Valley in Shamirpet and reviewed the progress on the manufacturing of indigenous COVID-19 vaccine 'Covaxin'.

In Ahmedabad, he reviewed the vaccine development process at the Zydus Cadila research centre in Changodar industrial area.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.